NR2F6 and melanoma: S2E), while NR2F6 KD notably delayed melanoma growth in mice treated with anti–PD-1 antibodies (Fig. 2C), suggesting that NR2F6 loss converts B16F10 cells from an immunologically cold to warm status to allow a response to ICT.